fig1 - 3 illustrate a multi - pharmaceutical storage , mixing and dispensing vial 2 including a container assembly 4 housed within a housing 6 . housing 6 includes a generally cylindrical , hollow cap assembly 8 rotatably mounted to a base 10 . container assembly 4 includes a cup - shaped container 12 , preferably made of glass , having an open end 14 and a closed end 16 . open end 14 has a lip 18 . container 12 has an inner wall 20 defining an upper cylindrical wall portion 22 and a lower cylindrical wall portion 24 . wall portion 22 is a somewhat larger diameter than wall portion 24 , the two wall portions being joined at a ledge 26 . an elastomeric seal ring 28 is positioned snugly against upper cylindrical wall portion adjacent ledge 26 . seal ring 28 is made from a pharmaceutical compatible material , such as 50 durometer silicone rubber . elastomeric seal ring 28 has a central hole 30 in which the distal end 32 and of a plug 34 is lodged . in the as - shipped , pre - use condition of fig1 and 3 , plug 34 and seal ring 28 act as a fluid seal or barrier 37 in container 12 . fluid passage through hole 30 is provided by pushing on an extension 36 of plug 34 so to overlap axial slots 38 with hole 30 . in this position , plug 34 is still retained within seal ring 28 , but fluid passage through hole 30 is achieved . plug 34 / extension 36 is made from a lubricous material , to minimize friction within hole 30 , such as ptfe . this movement of plug extension 36 and plug 34 is discussed below . container assembly 4 also includes an elastomeric convex septum 40 having a periphery 42 that engages open end 14 and around lip 18 of container 12 . septum 42 is made from a pharmaceutical compatible material , such as 60 durometer silicone rubber . septurn 42 is secured in place by a metal , preferably aluminum , retaining band 44 . septum 40 has a convex central portion 46 and a needle - pierceable region 48 at the center of central portion 46 . portion 48 is slightly dished to help in the insertion of a needle cannula , not shown , through septurn 40 at portion 48 . septum 40 and inner wall 20 define a sealed interior 52 of container assembly 4 . barrier 37 separates sealed interior 52 into a first or upper interior region 54 between septum 40 and barrier 37 and a second or lower interior region 56 defined between barrier 37 and closed end 16 of container 12 . first and second pharmaceutical components 58 , 60 are housed within first and second interior regions 54 , 56 , respectively . in the disclosed embodiment , first pharmaceutical component is a liquid and second pharmaceutical component is dry . however , both pharmaceutical components could be liquids , the dry pharmaceutical component could be a slurry and the locations of the liquid and dry pharmaceutical components in the first and second housings could be reversed . dry pharmaceutical component 60 is an lyophilized pharmaceutical component . container 12 could be used to create the lyophilized component . this is done by adding an appropriate amount of a liquid or slurry pharmaceutical component used to create second , dry component 60 . the container 12 is then placed in the lyophilization oven and the volatile components are driven off until a suitably dried second pharmaceutical component 60 is achieved . container assembly 4 can then be assembled , adding first pharmaceutical component 58 to first interior region 54 after installing barrier 37 and just prior to sealing open end 14 with septum 40 and retaining band 44 . a user could , if desired , dislodge plug 34 from hole 30 by simply pressing on needle - pierceable portion 48 of septum 40 . this would drive plug extension 36 and thus plug 34 away from convex septum 40 until axial slots 38 are aligned with hole 30 . this alignment , as shown in fig3 a , permits the liquid first pharmaceutical component 58 to flow into second interior region 56 and mix with second pharmaceutical component 60 . due in part to the natural resilience of septum 40 , septum 40 returns to its normal , convex shape , see fig3 b , once released by the user . once components 58 , 60 are suitably mixed , user can then invert container assembly 4 and access the interior 52 using a needle cannula of a syringe to pierce portion 48 of septurn 40 in a conventional manner . since septum 40 returns to its pre - use condition , an overpressure within sealed interior 52 is eliminated . housing 6 is used for several purposes . it provides a physical protection to container 12 , helping to protect the container against physical damage . housing 6 also covers and thus provides a needle cannula shield to prevent the premature access by a needle cannula into sealed interior 52 prior to mixing . housing 6 also provides a mechanical advantage for the user in driving plug 34 partly through hole 30 of seal ring 28 . base 10 , typically polycarbonate , includes a support surface 62 against which closed end 16 of container 12 rests . support surface 62 is surrounded by an annular space 64 . an outer surface 66 of base 10 partly defines annular space 64 . surface 66 has a number of openings 67 partly bounded by cam ramped surfaces 68 formed in outer surface 66 and used for purposes described below . base 10 also has numerous cut - outs 70 along its lower edge to enhance gripping by the user . cap assembly 8 includes a generally cylindrical upper housing 72 , also typically made of polycarbonate , having externally extending ramped camming lugs 74 configured to fit within openings 67 in outer surface 66 . a number of axially extending slots 78 are formed at lower end 76 of housing 72 to facilitate assembly . slots 78 permit lower end 76 to be deflected inwardly when inserting lower end 76 into annular space 64 and then permit segments of the lower end defined between slots 78 to spring outwardly with ramped camming lug 74 engaged within openings 67 formed in surface 66 . the upper end 80 of upper housing 72 is closed except for a central opening 82 sized and positioned to accept needle pierceable portion 48 of septum 40 . upper end 80 includes a ledge 84 and a slightly concave portion 86 within which central opening 82 is formed . cap assembly 8 also includes a needle cannula shield 88 which is made of a material resistant to puncture by a needle cannula , typically aluminum . shield 88 has a periphery 90 sized to fit snugly , but not with a force fit , against a circumferential shoulder 92 adjacent ledge 84 . shield 88 includes a pin 94 extending downwardly through a corresponding hole 96 in ledge 84 . twisting the two components of housing 6 , that is cap assembly 8 and base 10 , relative to one another , causes upper housing 72 to move downwardly , that is in the direction of arrow 98 in fig3 relative to base 10 through the engagement of lugs 74 with ramped surfaces 68 . this action forces convex central portion 46 of septum 40 in the direction of arrow 98 primarily due to the engagement of concave portion 86 of upper end 80 of upper housing 72 . such axial movement almost immediately causes portion 46 of septum 40 to engage the upper end 50 of plug extension 36 , thus forcing plug 34 in the direction of arrow 98 . this movement causes that portion of plug 34 containing axial slots 38 to be captured within hole 30 of ring 28 , thus permitting first pharmaceutical component 58 to now drain down into and mix with second pharmaceutical component 60 through the now breached barrier 37 . see fig3 a . movement of cap assembly 8 in the direction of arrow 98 also causes distal end 100 of pin 94 to engage retaining band 44 of container assembly 4 , thus forcing pin 94 through hole 96 . the initial movement pin 94 within hole 96 is relatively unrestricted by the pin in the hole ; the pin , over most of its length , is undersized relative to the hole . however , the distal end 100 of pin 94 is slightly larger to create a snug fit of pin 94 within hole 96 . thus , as base 10 and upper housing 72 are rotated relative to one another , thus driving upper housing 72 in the direction of arrow 98 relative to base 10 , while holding vial 2 at an angle to the vertical , causes shield 88 to swing out of the way , thus uncovering needle - pierceable portion 48 of septum 40 during the initial portion of the movement . at the end of the movement of upper housing 72 relative to base 10 , the enlarged distal end 100 of pin 94 becomes snugly engaged within hole 96 so to maintain shield 88 in this septum - exposed position as shown in fig3 b . the nesting of periphery 90 of shield 88 within an annular region defined by shoulder 92 and ledge 84 helps prevent inadvertent or premature removal of shield 88 . however , after vial 2 has been activated by rotating base 10 relative to upper housing 72 , portion 48 of septum 40 is very accessible for cleaning , such as by swabbing with alcohol , and for access by a needle cannula into sealed interior 52 for access to mixed pharmaceutical 102 . in use , a vial 2 is provided with first and second pharmaceutical components 58 , 60 within interior regions 54 , 56 , such as a human growth hormone or a cytotoxin . to mix the pharmaceutical components , user rotates base 10 relative to upper housing 72 causing upper housing to move in the direction of arrow 98 relative to base 10 . this forces concave portion 86 against convex central portion 46 of septum 40 , thus driving plug 34 in the direction of arrow 98 and opening up fluid passageways between regions 54 , 56 along slots 38 . the movement of upper housing 72 towards base 10 also pops away shield 88 , thus exposing needle - pierceable portion 48 of septum 40 . with needle shield 88 pivoted out of the way , user can clean portion 48 , invert vial 2 , pass a needle cannula through portion 48 of septum 40 and withdraw the desired amount of the mixed pharmaceutical 102 . as shown in fig4 plug extension 36a could have a hollow interior 104 and could be sized to normally rest against septum 40 when in the pre - use condition of fig1 and 3 so that the interior is isolated from the first region 54 . this permits hollow interior 104 of plug extension 36a to house a third pharmaceutical component which would mix with the first and second pharmaceutical components 58 , 60 , when the vial is inverted as shown in fig3 b for a two - component pharmaceutical . the third pharmaceutical will flow out of the interior 104 and mix with the first and second components 58 , 60 . barrier 37 has been shown as including elastomeric seal ring 28 and plug 34 . other types of rupturable barriers can be used as well . a thin , taut elastomeric diaphragm could be used as a barrier with an axial extension of the septum extending towards the barrier with the tip of the extension positioned a short distance from the taut membrane . the tip of the septum extension could be sharpened so that , when it touches the taut membrane , the membrane ruptures providing a large opening between the two interior regions with little force and little movement . also , a solid , brittle barrier with a notched or weakened region could be used ; when the tip of a septum extension or some other mechanical coupler pushes against the brittle barrier , the barrier breaks , opening a pathway between the interior regions . the present invention provides a significant advantage by using convex septum 40 ; after mixing , any overpressure in septum 52 is eliminated since the septum returns to its premixed condition . however , the invention could be used with an axially moveable piston 106 in place of the septum . see fig5 . the piston would be mechanically coupled to a barrier so that only a small movement of the piston would cause the barrier to breached . thus , rather than relying on a pneumatic pressure increase created by movement of the piston , the distance the piston must move can be minimized and still cause the rupture or other breach of the barrier so that only a small overpressure may be created . also , in appropriate circumstances , the septum could be a flat septum which returns to its original flat configuration after the barrier has been breached . this may , however , dictate a relatively short distance of movement by the septum to create a breached barrier . other modifications and variations can be made to the disclosed embodiments without deviating from the subject of the invention as defined in the following claims .
a pharmaceutical storage , mixing and dispensing vial is used to store first and second pharmaceuticals , mix the pharmaceuticals , and then provide access to the mixed pharmaceutical via a needle canula . the vial includes a container having an open end covered by a convex septum . a barrier within the container interior divides the interior into first and second interior regions housing the pharmaceuticals . the barrier has a plug sealing a hole the plug having an extension extending to the septum . the plug is driven from the opening by the plug extension when the septum is deflected into the container interior . the septum then naturally returns to its undeflected state to eliminate pressurization of the container interior .